Term
| inhaled antibiotics for treatment of CF |
|
Definition
| TOBI, Aztreonam, Colistin |
|
|
Term
| oral antibiotics for treatment of CF |
|
Definition
|
|
Term
|
Definition
| B2 agonists (albuterol) and anticholinergics (ipatropium), hypertonic saline, pulmozyme, physiotherapy, fluticasone (only if responsive airway dx) |
|
|
Term
| other anti-inflammitories for pulmonary dx management |
|
Definition
| NSAIDs and prednisone QOD |
|
|
Term
| frequency of aminoglycoside |
|
Definition
| chronic suppressive therapy of pseudomonas: BID 30d on, 30d off; acute pulmonary exacerbation: ONCE DAILY |
|
|
Term
| when is aztreonam used in CF |
|
Definition
| for chronic suppressive therapy (p aeruginosa, for kids >7 yrs with FEV1 <25 or >75 predicted or B. cepacia) |
|
|
Term
| distribution and clearance in CF patients |
|
Definition
| increased lean body, increased Vd causing hypophilic drugs to have HIGHER DOSES (TOBI), increased clearance of B-lactams (maximize dose) |
|
|
